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Elevated blood pressure (BP) is a major independent risk fac-
tor for the development of cardiovascular disease, and its varia-
tion at day or night depends on a phenomenon called circadian 
rhythm. This BP variation (dipping phenomenon) consists in 
a decrease of mean nighttime BP of 10–20% from daytime BP 
and occurs as a normal physiologic change. However, these 
changes do not occur in some individuals. In a cohort study 
of the Spanish Society of Hypertension Ambulatory Blood 
Pressure Monitoring Registry, 35% of untreated patients and 
40% of treated patients had no dipping pattern.1 Subjects with 
a nondipping pattern had more hypertension-induced organ 
damage such as left ventricular hypertrophy, microalbuminu-
ria, and reduced arterial compliance, and had worse prognosis 
in terms of cardiovascular events.2,3
Nocturnal hypertension is defined as BP >120/70 mm Hg 
at night.4 Nocturnal hypertension is a frequently overlooked 
condition due to the limited use of ambulatory BP measure-
ment (ABPM).5 Although high nocturnal BP is sometimes 
accompanied by a nondipping pattern, they are not always 
present together and their significance could be different. 
While a nondipping profile reflects an inadequate mecha-
nism of BP regulation, nocturnal BP represents the minimal 
BP levels that the subjects need for an adequate organ perfu-
sion.6 Consequently, absolute values of nocturnal BP could 
be a good opportunity to evaluate the relationships among 
BP and some physiological factors. Maintaining a high BP 
at night overloads the cardiovascular system with a negative 
impact on the heart and vascular structures.6 Fagard et al.7 
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OBJECTIVE
The aim was to evaluate the relationships among insulin resistance 
markers and nocturnal and diurnal hypertension in normotensive or 
mildly untreated hypertensive adults.
METHODS
The study was performed in both female and male adults referred to the 
Cardiometabolic Unit of the Hospital San Martín, La Plata, Argentina, in 
order to perform an ambulatory blood pressure measurement (ABPM) 
for the evaluation of a possible hypertensive disorder. The population 
was stratified according to their ABPM in: 1—presence or absence of 
diurnal hypertension and 2—presence or absence of nocturnal hyper-
tension; both conditions were analyzed separately. Fasting plasma insu-
lin (FPI), homeostasis model assessment of insulin resistance (HOMA-IR), 
and triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C) ratio 
were used as surrogate markers of insulin resistance and compared 
among subjects with vs. without diurnal or nocturnal hypertension.
RESULTS
One hundred and five patients, 55 women, 47 (11) years old, and 
50 men, 44 (16) years old, were included. Diurnal and nocturnal 
hypertension were found in 60% and 64% of the sample, respectively. 
There were no significant differences among the levels of insulin resist-
ance markers between individuals with or without diurnal hyperten-
sion. In contrast, individuals with nocturnal hypertension were more 
insulin resistant irrespectively of whether they were evaluated using FPI 
(P = 0.016), HOMA-IR (P = 0.019), or TG/HDL-C ratio (P = 0.011); FPI dif-
ferences remained significant after adjustment for sex, age, and obesity 
indicators (P = 0.032).
CONCLUSIONS
Nocturnal but not diurnal hypertension was related to higher levels 
of 3 insulin resistance markers in normotensive and untreated mildly 
hypertensive adults; this relationship seems partially independent of 
obesity.
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assessed the prognostic significance of nighttime and day-
time ambulatory BP by performing a meta-analysis in 3,468 
hypertensive patients. Daytime and nighttime systolic BP 
predicted all-cause and cardiovascular mortality, coronary 
heart disease, and stroke. Nonetheless, when these BP were 
entered simultaneously into the models, nighttime BP pre-
dicted all outcomes, whereas daytime BP did not add prog-
nostic precision. Remarkably, after adjustments, absolute 
nocturnal BP values were stronger predictors of cardiovas-
cular disease than nondipping patterns.
Many factors were postulated as nocturnal hypertension 
producers. Some of these pathophysiological mechanisms, 
such as inflammation, nocturnal autonomic nervous system 
imbalance, and kidney limitations for sodium metabolism, 
are also states for insulin resistance/hiperinsulinemia.8,9 
Furthermore, in a study performed in obese children and 
adolescent, insulin resistance was associated to elevated 
nocturnal, but not daytime, BP.10 The authors propose that 
the early increment of nocturnal BP associated to hiperin-
sulinemia in children and adolescent may be a harbinger of 
hypertension-related insulin resistance in adults.
Although some early studies supported this notions,11 
others did not.12 Furthermore, to the best of our knowledge, 
the relationships among insulin resistance and nocturnal vs. 
diurnal BP has not been extensively evaluated in normo-
tensive or mildly untreated hypertensive adults. In conse-
quence, the aim of this study was to evaluate the relationships 
among insulin resistance markers and nocturnal and diurnal 
hypertension.
MATERIAL AND METHODS
The sample consisted of adults of both sexes, aged 18–85, 
referred to the Cardiometabolic Unit of the Hospital San Martín, 
La Plata, Argentina—a specialized hypertension centre—
enrolled to perform an ABPM for the evaluation of a possible 
hypertensive disorder. Written informed consent was obtained 
from all participants. In order to define office BP, a specially 
trained nurse performed 3 BP measurements with a validated 
automatic oscillometric BP monitors (OMRON HEM 705 CP), 
appropriate arm sleeves, a previous 5 minutes resting period 
and in seated position, with the arm at heart level. Office BP 
was defined as an average of 3 determinations. Individuals with 
a previous diagnosis of cardiovascular disease, hypertension or 
diabetes, office BP ≥160/100 mm Hg or taking antihypertensive 
drugs were excluded. On the same day, an ABPM was initiated 
with a Spacelabs 90207. Measurements were scheduled every 
15 minutes during the day and every 20 minutes at night. Only 
ABPM with ≥70% of successful measurements and at least 1 
record per hour were considered valid. In order to evaluate 
quality of habitual nocturnal resting, the usual sleep duration, 
loud snoring, and daytime sleepiness were investigated. Also, 
at the end of the monitoring session, the participants filled a 
questionnaire focused on the quality of sleep during the over-
night BP monitoring. The questionnaire included the hour of 
retiring, the hour of rising, the perceived duration of sleep, and 
the difference in sleep duration compared to the usual (ie, in the 
absence of ABP monitoring) scored as: 1—usual, 2—< 2 hours 
less than usual, and 3—> 2 hours less than usual.
Night and day period, defined taking into account the 
patient’s diary, were analyzed separately. Hypertension dur-
ing daily activities was defined as day ABPM ≥135/85 mm 
Hg; nocturnal hypertension was defined as ABPM during 
night rest ≥120/70 mm Hg.
Weight was determined with subjects wearing light cloth-
ing and no shoes. Height was also measured without shoes, 
using a metallic metric tape, and body mass index (BMI) was 
calculated with the formula weight (kg)/height2 (m). Waist 
circumference was measured with a relaxed abdomen using 
a metallic metric tape on a horizontal plane above the iliac 
crest; neck circumference was measured on the middle of the 
neck, between the mid-cervical spine and the superior line of 
the cricothyroid membrane in a standing position. Metabolic 
assessment was performed under fasting conditions in the 
early morning. Peripheral blood samples were obtained to 
measure concentrations of plasma glucose, total cholesterol, 
triglycerides (TG), high-density lipoprotein cholesterol 
(HDL-C), and fasting plasma insulin (FPI). Low-density 
lipoprotein cholesterol was estimated by the Friedewald for-
mula.13 FPI concentrations were determined using immuno-
assay of paramagnetic microparticles (Ultrasensitive insulin 
Acces Beckman Coulter, dynamic range: 0.03–300 µIU/ml, 
sensitivity: 0.03 µIU/ml precision: <10% coefficient of vari-
ation). The homeostasis model assessment of insulin resist-
ance (HOMA-IR) was calculated using the formula [FPI 
(µU/ml) × glucose (mg/dl/18)/22.5].14
The experimental population was dichotomously classi-
fied according to their ABPM in: 1—presence or absence of 
diurnal hypertension and 2—presence or absence of noctur-
nal hypertension; both conditions were analyzed separately. 
Values for age, heart rate, BP, BMI, total cholesterol, HDL-C 
and low-density lipoprotein cholesterol, and glucose were 
compared between subjects with vs. without diurnal or noc-
turnal hypertension using Student “t” test for independent 
samples. This procedure produces 2 tests of the difference 
between the 2 groups. One test assumes that the variances of 
the 2 groups are equal and a in a second test equal variances 
are not assumed. This assumption is tested by the Levene sta-
tistic and the proper P values are selected.
FPI, HOMA-IR, and TG/HDL-C were used as surrogates 
markers of insulin resistance and compared between sub-
jects with vs. without diurnal or nocturnal hypertension. 
Since insulin resistance is associated to obesity, covariance 
analysis (univariate general lineal model) including BMI, 
waist circumference, and neck circumference as covari-
ates, was performed to control the differences among these 
parameters. Finally, since some subjects had both nocturnal 
and diurnal hypertension, a further comparison between 
subjects with isolated diurnal hypertension vs. isolated noc-
turnal hypertension was performed.
All significant tests were 2-tailed, and P values <0.05 were 
considered statistically significant. Statistical analyses were 
performed using SPSS (SPSS, Chicago, IL).
RESULTS
The initial enrolment included 122 subjects without his-
tory of diabetes who were not taking antihypertensive 
drugs; during the evaluation period 2 individuals with BP 
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≥160/100 mm Hg and 1 with glucose levels >126 mg/dl were 
excluded. One hundred and five patients, 55 women, 47 (11) 
years old, and 50 men, 44 (16) years old (P  =  0.153), had 
valid day and night ABPM and completed all the laboratory 
data necessary for the present study. There were no signifi-
cant differences in terms of age (P = 0.364), BMI (P = 0.344), 
and office BP (P = 0.324 and P = 0.909 for systolic and dias-
tolic, respectively) between individuals that completed the 
study and those who did not. Characteristics of the sample 
are shown in Table 1.
There were not significant differences in the usual dura-
tion of the sleep among individuals with vs. without noc-
turnal hypertension, 6.9 (1.3) vs. 6.8 (1.1) h, P  =  0.490. 
Furthermore, the prevalence of snoring (60.9% vs. 64.9%, 
P  =  0.695) and daytime sleepiness (29.7% vs. 37.8%, 
P = 0.400) were similar in both groups. The distribution of 
perceived sleep duration in terms of difference from usual 
was: usual 78.7%, <2 hours less than usual 14.8%, and >2 
hours less than usual 5.5%. Diurnal and nocturnal hyperten-
sion were found in 60% and 64% of the sample, respectively. 
There were no significant differences in terms of age, office 
BP, BMI, waist circumference, neck circumference, and 
clinic chemistry values among individuals with vs. without 
diurnal hypertension (Table 2). These findings were similar 
when the comparison was made between subjects with vs. 
without nocturnal hypertension except for TG, which was 
significantly higher in those with nocturnal hypertension. 
Remarkably, there were no significant differences in obesity 
markers (Table 2).
There were no significant differences in the levels of insu-
lin resistance surrogates (FPI, HOMA-IR, and TG/HDL-C 
ratio) between individuals with or without diurnal hyperten-
sion. In contrast, individuals with nocturnal hypertension 
were more insulin resistant irrespectively of whether they 
were evaluated using FPI, HOMA-IR, or TG/HDL-C ratio 
(Table 3). Higher FPI concentrations in this group remained 
significant after adjustment for sex, age, and obesity indica-
tors. Moreover, obesity adjusted differences in HOMA-IR 
values had marginal significance.
Individuals with isolated nocturnal hypertension, com-
pared to those with isolated diurnal hypertension, had 
significantly higher levels of FPI (P  =  0.015), HOMA-IR 
(P = 0.010), and TG/HDL-C ratio (P = 0.038) and these dif-
ferences remained significant after adjustment for sex, age, 
and obesity indicators (P values 0.033, 0.013, 0.015, respec-
tively). The comparisons of FPI levels between individuals 
with vs. without diurnal hypertension (i), with vs. without 
nocturnal hypertension (ii), and with isolated diurnal vs. 
isolated nocturnal hypertension (iii) can be seen in Figure 1.
DISCUSSION
Our study shows that nocturnal but not diurnal hyper-
tension was related to higher levels of 3 insulin resistance 
Table 1. Demographic and metabolic characteristics of the study population
Women (n = 55) Men (n = 50)
Mean (SD) Mean (SD) P*
Age (years) 48 (11) 44 (16) 0.161
BMI (kg/m2) 30.0 (5.0) 29.0 (4.6) 0.327
Waist circumference (cm) 94 (17) 100 (14) 0.058
Neck circumference (cm) 37 (2) 43 (10) <0.001
Systolic office BP (mm Hg) 125 (20) 135 (10) <0.001
Diastolic office BP (mm Hg) 79 (14) 84 (9) 0.050
Diurnal systolic ABPM (mm Hg) 130 (8) 134 (7) 0.007
Diurnal diastolic ABPM (mm Hg) 83 (8) 86 (7) 0.047
Nocturnal systolic ABPM (mm Hg) 117 (11) 120 (8) 0.142
Nocturnal diastolic ABPM (mm Hg) 69 (9) 72 (8) 0.175
Creatinine (mg/dl) 0.8 (0.1) 0.9 (0.1) <0.001
Uric acid (mg/dl) 4.1 (1.1) 5.5 (1.1) <0.001
Glucose (mg/dl) 91 (10) 96 (12) 0.021
Total cholesterol (mg/dl) 191 (35) 187 (29) 0.619
LDL-C (mg/dl) 121 (31) 120 (24) 0.904
HDL-C (mg/dl) 46 (11) 39 (7) <0.001
Triglicerydes (mg/dl) 122 (54) 149 (87) 0.064
FPI (µU/ml) 7.0 (4.9) 6.9 (4.8) 0.899
Abbreviations: ABPM, ambulatory blood pressure monitoring; BMI, body mass index; BP, blood pressure; FPI, fasting plasma insulin; HDL-C, 
high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
P*: independent samples “t” test.
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markers (FPI, HOMA-IR, and TG/HDL-C ratio) in normo-
tensive and mildly hypertensive adults at office. The results 
are in concert with previous reports of a positive relation-
ship between insulin resistance and nocturnal hypertension 
in obese children and adolescents.10
Obesity, high levels of FPI, HOMA-IR, TG, and low 
levels of HDL-C during childhood and adolescence are 
related to the subsequent development of hypertension 
during adulthood.15 Although insulin resistance and 
obesity are strongly related, a recently published study16 
showed that insulin resistance has a synergistic effect on 
the obesity-hypertension association in young adults, 
indicating that the role of adiposity in the development 
of hypertension is modified by insulin resistance. Thus, 
excessive adiposity and high levels of insulin resistance 
markers in childhood and adverse longitudinal changes 
through young adulthood characterize the early natural 
history of hypertension.
Table 3. Comparison of the markers of insulin resistance between individuals with vs. without diurnal hypertension and with vs. without 
nocturnal hypertension
Diurnal hypertension Nocturnal hypertension
No (n = 42) Yes (n = 63) No (n = 38) Yes (n = 67)
Mean (SD) Mean (SD) P* P** Mean (SD) Mean (SD) P* P**
FPI (µU/ml) 6.8 (3.4) 7.0 (5.6) 0.803 0.431 5.7 (2.6) 7.7 (5.6) 0.016 0.032
HOMA-IR 1.6 (0.8) 1.7 (1.5) 0.667 0.424 1.3 (0.7) 1.8 (1.5) 0.019 0.058
TG/HDL-C ratio 3.1 (1.6) 3.7 (2.6) 0.209 0.376 2.8 (1.5) 3.8 (2.5) 0.011 0.198
Abbreviations: FPI, fasting plasma insulin; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin 
resistance; TG, triglycerides.
P*: unadjusted, P**: adjusted for age, sex, BMI, and waist and neck circumference.
Table 2. Comparison of the characteristics of individuals with vs. without diurnal hypertension and with vs. without nocturnal hypertension, 
both defined using ambulatory blood pressure monitoring (ABPM)
Diurnal hypertension Nocturnal hypertension
No (n = 42) Yes (n = 63) P* No (n = 38) Yes (n = 67) P*
Age (years) 46 (13) 47 (14) 0.661 46 (13) 47 (14) 0.775
BMI (kg/m2) 30.5 (4.7) 28.9 (4.9) 0.90 28.9 (4.8) 29.9 (4.9) 0.340
Waist circumference (cm) 97 (13) 97 (18) 0.819 96 (10) 98 (19) 0.553
Neck circumference (cm) 41 (11) 39 (4) 0.438 38 (3) 41 (9) 0.119
Office heart rate (beats/min) 73 (16) 74 (20) 0.719 75 (12) 73 (21) 0.729
Systolic office BP (mm Hg) 126 (12) 132 (20) 0.130 128 (12) 131 (20) 0.337
Diastolic office BP (mm Hg) 78 (9) 83 (13) 0.021 79 (8) 83 (13) 0.097
Diurnal heart rate (beats/min) 76 (10) 80 (9) 0.043 78 (11) 79 (9) 0.654
Diurnal systolic ABPM (mm Hg) 125 (5) 137 (6) <0.001 128 (8) 134 (7) <0.001
Diurnal diastolic ABPM (mm Hg) 78 (5) 89 (6) <0.001 80 (6) 87 (7) <0.001
Nocturnal heart rate (beats/min) 65 (8) 68 (9) 0.149 65 (10) 68 (8) 0.178
Nocturnal systolic ABPM (mm Hg) 113 (8) 122 (9) <0.001 110 (7) 123 (7) <0.001
Nocturnal diastolic ABPM (mm Hg) 65 (6) 74 (8) <0.001 63 (5) 75 (7) <0.001
Creatinine (mg/dl) 0.8 (0.2) 0.8 (0.2) 0.620 0.8 (0.2) 0.8 (0.1) 0.674
Uric acid (mg/dl) 4.8 (1.5) 4.7 (1.1) 0.853 4.5 (1.4) 4.8 (1.2) 0.270
Glucose (mg/dl) 94 (11) 94 (11) 0.902 92 (10) 94 (12) 0.376
Total cholesterol (mg/dl) 192 (34) 187 (31) 0.479 193 (33) 187 (31) 0.396
LDL-C (mg/dl) 124 (29) 118 (26) 0.300 126 (28) 117 (27) 0.102
HDL-C (mg/dl) 44 (12) 42 (8) 0.264 44 (11) 42 (9) 0.276
Triglicerydes (mg/dl) 123 (51) 142 (84) 0.155 112 (50) 147 (81) 0.008
Variables expressed as mean and SD. Abbreviations: BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein choles-
terol; LDL-C, low-density lipoprotein cholesterol.
P*: independent samples “t” test.
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In this context, Lurbe et  al.10 have suggested that the 
early increment of nocturnal BP and heart rate associated to 
hyperinsulinemia may be a harbinger of hypertension in the 
adult life and may contribute to a heightened cardiovascular 
risk. However, data analyzing the relationship between insu-
lin resistance and nocturnal hypertension in adults is scanty 
and yields conflicting results. Most of the studies have ana-
lyzed nocturnal BP changes using the dipping pattern and 
not the absolute values of BP during nocturnal rest, and/
or were focused on patients with hypertension and some 
comorbidities such as diabetes, renal disease, and obstruc-
tive sleep apnea.17,18 Remarkably, in a study performed in 
uncomplicated and untreated hypertensive individuals, noc-
turnal hypertension was more frequent than nondipping 
patterns. Furthermore, it was associated to organ damage, 
independently of dipping/nondipping status and it was more 
reproducible than the dipping patterns.19 Consequently, 
some of the previously published studies could not be appro-
priate to evaluate the early relationships among the values of 
nocturnal BP and insulin resistance. In contrast, our study 
focused on nocturnal hypertension and was performed in 
nondiabetic adults, without neither known cardiovascular 
disease nor markedly elevated BP, and clearly shows the rela-
tionships between nocturnal BP and insulin resistance.
Miomi et  al.,20 in a recently published study performed 
in young normotensive women with polycystic ovary syn-
drome, found that nighttime systolic and diastolic BP were 
significantly higher in obese insulin resistant women com-
pared to noninsulin resistant obese women. Remarkably, 
all of these studies have compared the values of nocturnal 
BP between individuals defined categorically as insulin 
resistant or not. In contrast, we used a somewhat different 
approach. Based on current recommendations,21 our sam-
ple was divided as having or not nocturnal hypertension and 
the differences in FPI, HOMA-IR, and TG/HDL-C levels 
were analyzed as continuous variables. Using this approach, 
individuals with nocturnal hypertension had clearly the 
highest values of all insulin resistant surrogates. The over-
activity of the sympathetic nervous system could work as a 
link between hiperinsulinemia and higher values of noctur-
nal BP.8 However, no differences in the heart rate were found 
between individuals with vs. without nocturnal hyperten-
sion in this study.
Obesity, associated or not to obstructive sleep apnea, 
could be a link between insulin resistance and nocturnal 
hypertension. However, our data suggest that the effect of 
insulin resistance/hiperinsulinemia on nocturnal BP could 
be partially independent of obesity. First, as Table 2 shows, 
there are no differences in BMI, waist circumference, or neck 
circumference between individuals with vs. without noctur-
nal hypertension. Additionally, higher FPI levels observed in 
subjects with nocturnal hypertension remained significant 
after the adjustment for these obesity parameters.
Since a polysomnography was not performed, we can-
not discard obstructive sleep apnea. Indeed, the sample had 
a high prevalence of habitual snoring and daytime sleepi-
ness, probably related to overweight and obesity (mean BMI 
~30 kg/m2, Table 2). However, the usual duration of the sleep 
and percentages of habitual snoring and daytime sleepi-
ness were similar in individuals with vs. without nocturnal 
hypertension.
There are several limitations of this study that must be 
acknowledged. Firstly, specific measurements of insulin action 
were not performed. Since direct measurements of muscular 
Figure  1. Comparison of FPI levels (mean ± SE) between individuals 
with vs. without diurnal hypertension (a), with vs. without nocturnal 
hypertension (b), and isolated diurnal vs, isolated nocturnal hypertension 
(c); P values are adjusted for sex, age, BMI, and neck and waist circumfer-
ence. Abbreviations: ABPM, ambulatory blood pressure monitoring; BMI, 
body mass index; FPI, fasting plasma insulin.
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uptake of glucose are neither practical nor widely available, 
several approaches to estimate insulin resistance have been 
proposed and surrogate markers are commonly used in the 
clinical setting. In our study, we evaluated the insulin resist-
ance level using 3 validated surrogates: FPI, HOMA-IR, and 
TG/HDL-C. Supporting this notion, Abbasi et al. have shown, 
in 758 apparently healthy nondiabetic individuals, that 
HOMA-IR and FPI correlated significantly and in a similar 
degree with steady-state plasma glucose concentration dur-
ing the insulin suppression test.22 Furthermore, McLaughlin 
et  al. have communicated significant correlations between 
steady-state plasma glucose and TG/HDL-C and between 
steady-state plasma glucose and FPI.23 Thus, we believe that 
the level of insulin resistance was reasonably estimated in 
our study. Secondly, the results are based on one BP moni-
toring only. However, in a study performed on >650 never-
treated hypertensive subjects in which 2 consecutive ABPM 
were performed, the reproducibility of nocturnal hyperten-
sion was >70%, remarkably higher than nondipping pattern. 
Furthermore, a variable pattern (as they changed their profile 
from one to the other ABPM session) was observed in <10% of 
the subjects.19 Thirdly, sleep deprivation induced by cuff infla-
tions during overnight BP monitoring might interfere with 
the interpretations of our results. However, Verdecchia et al.24 
showed that the independent prognostic value of nighttime 
BP for total cardiovascular end points disappeared only when 
perceived sleep deprivation >2 hours. In our study ~95% of 
subjects reported a sleep duration perceived as usual, or <2 
hours less than the usual. Consequently, it seems unlikely for 
the results to be substantially modified by changes in the usual 
pattern of nocturnal rest. Finally, the sample is relatively small 
and biased since the individuals included were referred to a 
specialized diagnostic center in order to perform an ABPM 
for a possible hypertensive disorder. This later issue could 
explain the high prevalence of abnormal ABPM. Nonetheless, 
our data support the use of ABPM in this specific population 
(subjects with normal or mildly elevated office BP) since the 
finding of nocturnal hypertension (combined or isolated) 
suggests an unfavorable cardiometabolic profile.
In conclusion, despite these limitations our results support the 
hypothesis regarding nocturnal hypertension as an early mani-
festation of hypertension-related insulin resistance in adults.
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